Mode
Text Size
Log in / Sign up

Ultrasound-guided mammotome surgery reduces operation time, blood loss, and healing time for benign breast tumorsMinimally invasive surgery shows better results for benign breast tumors

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider ultrasound-guided mammotome surgery to reduce operation time and blood loss in benign breast tumor cases.

This meta-analysis synthesized data from 8 studies to compare ultrasound-guided mammotome minimally invasive surgery against traditional open surgery for patients with benign breast tumors. The analysis included a total of 1909 patients to evaluate several perioperative and postoperative outcomes.

The meta-analysis reported significant improvements across all measured secondary outcomes. Specifically, ultrasound-guided mammotome surgery resulted in shorter operation times (MD = -12.79; 95%CI -14.04, -11.55; p < 0.00001) and reduced intraoperative blood loss (MD = -11.55; 95%CI -14.74, -8.36; p < 0.00001). Additionally, patients experienced faster healing times (MD = -2.73; 95%CI -4.03, -1.43; p < 0.00001) and lower complication rates (MD = 0.17; 95%CI 0.12, 0.26; p < 0.00001).

Clinicians may consider ultrasound-guided mammotome surgery as a more effective alternative to traditional open surgery for benign breast tumors based on these aggregated results. However, the evidence is based on a meta-analysis of 8 studies, and specific safety data or individual study limitations were not reported.

When a patient is diagnosed with a benign breast tumor, the surgical approach can significantly impact their recovery experience. New data comparing two methods suggests that a minimally invasive technique, guided by ultrasound and a mammotome device, offers several advantages over traditional open surgery.

By looking at data from 1,909 patients across eight different studies, researchers found that the minimally invasive approach led to shorter operation times and less blood loss during the procedure. Patients also experienced faster healing times and a lower rate of complications. These improvements suggest that the smaller, guided approach may be more efficient for the patient.

While these results are promising, it is important to remember that this information comes from a meta-analysis, which combines data from several different studies. Because the results are based on aggregated data, your specific experience may vary based on your unique health needs. Always talk to your doctor to decide which surgical path is right for you.

What this means for you:
Minimally invasive surgery for benign breast tumors can lead to faster healing and less blood loss than open surgery.

Common questions

How does minimally invasive surgery compare to traditional surgery for breast tumors?

Minimally invasive surgery guided by ultrasound and a mammotome device showed several benefits over traditional open surgery. Patients had shorter operation times, less blood loss during the procedure, and faster healing times. Additionally, the complication rate was lower with the minimally invasive approach.

Are there fewer complications with the minimally invasive method?

Yes, the data indicates a lower complication rate for patients undergoing ultrasound-guided mammotome minimally invasive surgery compared to those undergoing traditional open surgery. This finding was based on a review of 1,909 patients across eight different studies.

Does the minimally invasive surgery help with recovery time?

The results show that patients who underwent the minimally invasive procedure experienced faster healing times than those who had traditional open surgery. This suggests a quicker recovery process for those with benign breast tumors.

Study Details

Study typeMeta analysis
Sample sizen = 1,909
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
ObjectiveTo systematically analyze the efficacy of ultrasound-guided mammotome minimally invasive surgery and traditional open surgery in the therapy of benign breast tumors.MethodsA computerized search retrieved original literature on the therapeutic effects of ultrasound-guided mammotome minimally invasive surgery and traditional open surgery for benign breast tumors from authoritative databases, including CNKI, Wanfang, VIP, Web of Science, PubMed, ScienceDirect, Cochrane Library, and Embase. The search covered from database inception to January 2024, using a strategy of subject terms combined with free terms. The retrieved literature was screened, data were extracted, and quality was evaluated. Meta-analysis was performed using RevMan 5.4 software.ResultsA total of 8 literatures were included in the study, and a total of 1909 patients with benign breast tumors were found from 2018 to 2023. The results of meta-analysis showed that the operation time [MD = -12.79, 95%CI (-14.04, -11.55), < 0.00001], intraoperative blood loss [MD = -11.55, 95%CI (-14.74, -8.36), < 0.00001], healing time [MD = -2.73, 95%CI (-4.03, -1.43), < 0.00001] and complication rate [MD = 0.17, 95%CI (0.12, 0.26), < 0.00001] was apparently different from traditional open surgery ( < 0.05).ConclusionUltrasound-guided mammotome minimally invasive surgery can effectively shorten the operation time of patients with benign breast tumors, reduce intraoperative blood loss, promote healing, and reduce the risk of complications. The effect is better than that of traditional open surgery.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.